Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |
mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.00088 | 1 |
mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00087 | 1 |
mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.00094 | 1 |
mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.00087 | 1 |
mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.00083 | 1 |
mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.0007 | 1 |
mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.00089 | 1 |
mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.00051 | 1 |
mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.0006 | 1 |